nablaDFT: Large-Scale Conformational Energy and Hamiltonian Prediction benchmark and dataset.

Electronic wave function calculation is a fundamental task of computational quantum chemistry. Knowledge of the wave function parameters allows one to compute physical and chemical properties of molecules and materials. Unfortunately, it is infeasible to compute the wave functions analytically even for simple molecules.

Medical concept normalization in clinical trials with drug and disease representation learning.

Motivation: Clinical trials are the essential stage of every drug development program for the treatment to become available to patients. Despite the importance of well-structured clinical trial databases and their tremendous value for drug discovery and development such instances are very rare. Presently large-scale information on clinical trials is stored in clinical trial registers which are relatively structured, but the mappings to external databases of drugs and diseases are increasingly lacking.

Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models.

Generative models are becoming a tool of choice for exploring the molecular space. These models learn on a large training dataset and produce novel molecular structures with similar properties. Generated structures can be utilized for virtual screening or training semi-supervized predictive models in the downstream tasks.

Erratum: Addendum: Molecular Generation for Desired Transcriptome Changes With Adversarial Autoencoders.

[This corrects the article .].

Molecular Generation for Desired Transcriptome Changes With Adversarial Autoencoders.

Gene expression profiles are useful for assessing the efficacy and side effects of drugs. In this paper, we propose a new generative model that infers drug molecules that could induce a desired change in gene expression. Our model-the Bidirectional Adversarial Autoencoder-explicitly separates cellular processes captured in gene expression changes into two feature sets: those and to the drug incubation.

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery.

Modern computational approaches and machine learning techniques accelerate the invention of new drugs. Generative models can discover novel molecular structures within hours, while conventional drug discovery pipelines require months of work. In this article, we propose a new generative architecture, entangled conditional adversarial autoencoder, that generates molecular structures based on various properties, such as activity against a specific protein, solubility, or ease of synthesis.

3D Molecular Representations Based on the Wave Transform for Convolutional Neural Networks.

Convolutional neural networks (CNN) have been successfully used to handle three-dimensional data and are a natural match for data with spatial structure such as 3D molecular structures. However, a direct 3D representation of a molecule with atoms localized at voxels is too sparse, which leads to poor performance of the CNNs. In this work, we present a novel approach where atoms are extended to fill other nearby voxels with a transformation based on the wave transform.

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.

Deep generative adversarial networks (GANs) are the emerging technology in drug discovery and biomarker development. In our recent work, we demonstrated a proof-of-concept of implementing deep generative adversarial autoencoder (AAE) to identify new molecular fingerprints with predefined anticancer properties. Another popular generative model is the variational autoencoder (VAE), which is based on deep neural architectures.

The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology.

Recent advances in deep learning and specifically in generative adversarial networks have demonstrated surprising results in generating new images and videos upon request even using natural language as input. In this paper we present the first application of generative adversarial autoencoders (AAE) for generating novel molecular fingerprints with a defined set of parameters. We developed a 7-layer AAE architecture with the latent middle layer serving as a discriminator.